{"schema_version":"1","generated_at":"2026-10-28T06:07:58.457Z","data_as_of":null,"url":"https://www.findmykol.com/kol/angel-chan","json_url":"https://www.findmykol.com/kol/angel-chan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"angel-chan","name":"Angel Chan","credential":"MD, PhD","specialty":"Cardiovascular Disease","specialty_raw":"Cardiovascular Disease","therapeutic_area":"Cardiology","therapeutic_areas":["Cardiology"],"city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1558583948","orcid":"0000-0002-5788-333X","openalex":"A5088970707"},"summary":"Angel Chan is a Cardiology physician. OpenAlex indexes 36 publications with 228 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Cardiology"]},"scholarship":{"works_count":36,"cited_by_count":228,"h_index":10,"latest_activity_year":2024,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07549477","title":"A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer","phase":"NA","status":"RECRUITING","role":"Overall official","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT07549477","trial_url":"https://www.findmykol.com/trial/NCT07549477"},{"nct":"NCT02772367","title":"Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients","status":"RECRUITING","role":"Overall official","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT02772367","trial_url":"https://www.findmykol.com/trial/NCT02772367"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"CSL Behring","program_year":2023,"amount_usd":17.98,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1558583948"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1558583948","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cardiovascular","share_pct":90.1,"classes_total":10,"classes":[{"class":"Beta blocker","setting":"prescribed","share_pct":24.6,"drugs":[{"name":"Metoprolol Succinate","share_pct":68.7},{"name":"Labetalol Hcl","share_pct":20.2},{"name":"Carvedilol","share_pct":11.1}],"max_beneficiaries":null},{"class":"Statin","setting":"prescribed","share_pct":19.6,"drugs":[{"name":"Atorvastatin Calcium","share_pct":74.7},{"name":"Rosuvastatin Calcium","share_pct":25.3}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":9.9,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":9.9,"drugs":[{"name":"Eliquis","share_pct":67.5},{"name":"Xarelto","share_pct":32.5}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":23.8,"facility_pct":76.2},"source":"medicare"},"publications":{"total":49,"shown":5,"withheld":44,"matched_by":"OpenAlex author record","recent":[{"title":"Multiscale mapping of transcriptomic signatures for cardiotoxic drugs","year":2024,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-024-52145-4","status":"verified"},{"title":"The Society for Cardiovascular Magnetic Resonance Registry at 150,000","year":2024,"journal":"Journal of Cardiovascular Magnetic Resonance","source_url":"https://doi.org/10.1016/j.jocmr.2024.101055","status":"verified"},{"title":"Numerical Study on the Impact of Central Venous Catheter Placement on Blood Flow in the Cavo-Atrial Junction","year":2024,"journal":"Annals of Biomedical Engineering","source_url":"https://doi.org/10.1007/s10439-024-03463-7","status":"verified"},{"title":"Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin","year":2024,"journal":"Cardio-Oncology","source_url":"https://doi.org/10.1186/s40959-024-00257-7","status":"verified"},{"title":"894P AXEL: AXitinib-avELumab combination in recurrent or metastatic (RM) nasopharyngeal cancer (NPC)","year":2024,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2024.08.955","status":"verified"}],"source":"works"},"contact":{"address_1":"1275 YORK AVE","city":"New York","state":"NY","zip":"100656007","phone":"212-639-5154","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1558583948","source":"identity"},"similar":[{"name":"Deepak Bhatt","slug":"deepak-bhatt","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/deepak-bhatt","json_url":"https://www.findmykol.com/kol/deepak-bhatt/profile.json"},{"name":"Harlan Krumholz","slug":"harlan-krumholz","institution":"Yale School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/harlan-krumholz","json_url":"https://www.findmykol.com/kol/harlan-krumholz/profile.json"},{"name":"Scott Solomon","slug":"scott-solomon","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/scott-solomon","json_url":"https://www.findmykol.com/kol/scott-solomon/profile.json"},{"name":"Eric Topol","slug":"eric-topol","institution":"Scripps Research Institute (Scripps Research)","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/eric-topol","json_url":"https://www.findmykol.com/kol/eric-topol/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":44}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-06-14","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}